Showing 1551-1560 of 21412 results for "".
- Analysis: Ustekinumab, IL-23 Inhibitors Show Higher Drug Survival in Psoriasishttps://reachmd.com/news/analysis-ustekinumab-il-23-inhibitors-show-higher-drug-survival-in-psoriasis/2485295/A new Danish cohort study using data from the DERMBIO registry suggests ustekinumab was linked with the best 5-year survival of comparators in bionaive patients with psoriasis. The analysis included a total of 7,193 treatment
- Adenotonsillectomy in Pediatric Sleep-Disordered Breathing: A Shift Toward Surgical Intervention?https://reachmd.com/news/adenotonsillectomy-in-pediatric-sleep-disordered-breathing-a-shift-toward-surgical-intervention/2485266/Recent evidence shows that adenotonsillectomy improves growth and sleep-related outcomes in children with mild sleep-disordered breathing — a finding that coul
- Immune-Targeting Therapy with Aldesleukin: A New Frontier in Post-MI Carehttps://reachmd.com/news/immune-targeting-therapy-with-aldesleukin-a-new-frontier-in-post-mi-care/2485273/IVORY trials show low-dose aldesleukin after acute myocardial infarction reduced vascular inflammation by an average of nearly 8% on imaging and blood markers — a targeted signal in a defined post‑MI subgroup.
- Surgeon Introduces “Preservation Lasers” Protocol for No-Downtime, Collagen-Supportive Skin Renewalhttps://reachmd.com/news/surgeon-introduces-preservation-lasers-protocol-for-no-downtime-collagen-supportive-skin-renewal/2485260/As patients increasingly seek preventative, low-downtime skin treatments, combination laser protocols are emerging as a new standard in aesthetic care. Double board-certified facial plastic surgeon Anil Shah, MD, FACS, is responding to this shift with the launch of
- TOGETHER-PsA: Weight Loss Plus PsA Control with Ixekizumab and Tirzepatidehttps://reachmd.com/news/together-psa-weight-loss-plus-psa-control-with-ixekizumab-and-tirzepatide/2485259/In the phase 3b TOGETHER-PsA trial, ixekizumab (Taltz, Eli Lilly) used in combination with tirzepatide (Zepbound, Eli Lilly) was more effective than ixekizumab monotherapy in adults with active psoriatic arthritis (PsA) who also have obesity or are overweight with a
- Genomic Surveillance Unveils Mpox Clade IIb Spread in Kinshasahttps://reachmd.com/news/genomic-surveillance-unveils-mpox-clade-iib-spread-in-kinshasa/2485255/Public health investigators identified mpox Clade IIb introduced into Kinshasa; genomic assignment determined the responsible lineage as lineage G.1. Clinical presentation and immediate contact in
- Link Between Wildfire Events and Increased Cardiopulmonary Emergency Encountershttps://reachmd.com/news/link-between-wildfire-events-and-increased-cardiopulmonary-emergency-encounters/2485249/Cedars-Sinai Medical Center reported a 24% increase in emergency department encounters
- Evaluating Isoniazid Hepatotoxicity in Rheumatic Disease: Risks and Alternativeshttps://reachmd.com/news/evaluating-isoniazid-hepatotoxicity-in-rheumatic-disease-risks-and-alternatives/2485251/In patients with autoimmune rheumatic disease and prior DMARD‑related liver injury, isoniazid for latent tuberculosis infection (LTBI) was associated with a 27.6% incidence of hepatotoxicity in t
- Community-Based Asthma Interventions: Lessons from the Navajo Nationhttps://reachmd.com/news/community-based-asthma-interventions-lessons-from-the-navajo-nation/2485253/A recent study found that a community asthma program on the Navajo Nation increased pediatric asthma care‑seeking and awareness during the COVID‑19 pandemic. Program mo
- Exploring the Integration of ChatGPT Health with Apple Health: Clinical and Privacy Dimensionshttps://reachmd.com/news/exploring-the-integration-of-chatgpt-health-with-apple-health-clinical-and-privacy-dimensions/2485241/ChatGPT Health now integrates with Apple Health to provide personalized, AI